Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMINENT-Eye Ancillary Study
NCT03345901Phase 3Terminated
- Sponsor
- Jaeb Center for Health Research
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pemafibrate in diabetic retinopathy (DR), sponsored by Jaeb Center for Health Research. Started Jan 2018; status: terminated.
02
Drugs
pemafibrate
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on NCT03345901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345901.